OREX Related Downgrades

Jan 17, 2013 07:41 AM Brean Capital Downgrades Vivus (VVUS) to Sell, Low Qsymia Coverage Means Low Sales

Sep 21, 2011 07:54 AM Lazard Capital Downgrades Orexigen Therapeutics (OREX) to Sell

Jun 3, 2011 02:57 PM BofA/Merrill Lynch Cuts Orexigen (OREX) to Neutral Following Sell-Off

Feb 2, 2011 08:15 AM Jefferies Downgrades Orexigen Therapeutics (OREX) to Hold, Value Limited Just Beyond Cash After Contrave Failure

Feb 1, 2011 10:06 AM Leerink Swann Downgrades Orexigen Therapeutics (OREX) to Market Perform; Contrave CRL Asks For CV Study Pre-Approval

Feb 1, 2011 09:59 AM Canaccord Genuity Downgrades Orexigen Therapeutics (OREX) to Hold; Worst Case Scenario Occurred

Feb 1, 2011 09:28 AM Orexigen (OREX) Shares Downgraded at JPMorgan, Leerink, Cowen; More Likely to Follow

Dec 3, 2010 11:42 AM Rodman & Renshaw Downgrades Orexigen Therapeutics (OREX) to Underperform

Aug 4, 2010 08:56 AM Lazard Capital Downgrades Orexigen Therapeutics (OREX) to Hold

Jul 16, 2010 09:36 AM Davenport Downgrades Orexigen Therapeutics (OREX) to Neutral